Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial

Accumulating evidence implicates gut microbiota as promising targets for the treatment of type 2 diabetes mellitus (T2DM). With a randomized clinical trial, we tested the hypothesis that alteration of gut microbiota may be involved in the alleviation of T2DM with hyperlipidemia by metformin and a sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Xiaolin, Xu, Jia, Lian, Fengmei, Yu, Xiaotong, Zhao, Yufeng, Xu, Lipeng, Zhang, Menghui, Zhao, Xiyan, Shen, Jian, Wu, Shengping, Pang, Xiaoyan, Tian, Jiaxing, Zhang, Chenhong, Zhou, Qiang, Wang, Linhua, Pang, Bing, Chen, Feng, Peng, Zhiping, Wang, Jing, Zhen, Zhong, Fang, Chao, Li, Min, Chen, Limei, Zhao, Liping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964358/
https://www.ncbi.nlm.nih.gov/pubmed/29789365
http://dx.doi.org/10.1128/mBio.02392-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964358/
https://www.ncbi.nlm.nih.gov/pubmed/29789365
http://dx.doi.org/10.1128/mBio.02392-17

Ejemplares similares